{"transactions":[{"id":3569359,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-04-02T21:00:22.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":91139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in four equal installments on January 1, 2020, 2021, 2022 and 2023."}],"balance_after":91139,"derivative":{"exercise_price":3.79,"expiration_date":"2029-03-07","underlying":"Common Stock, par value $0.01 per share","underlying_shares":91139},"source":{"system":"sec-edgar","filing":"0001209191-19-022630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022630/doc4.xml","form_type":"4"}},{"id":3569358,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-02T21:00:22.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":18997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a deferred stock award of 18,997 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in equal installments on March 7, 2020, 2021 and 2022, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from March 7, 2019 to the earlier of (i) March 7, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above."}],"balance_after":73858,"source":{"system":"sec-edgar","filing":"0001209191-19-022630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022630/doc4.xml","form_type":"4"}},{"id":3569357,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-02T21:00:22.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":37995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 37,995 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 37,995 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (b) a deferred stock award of 13,852 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; and (c) 3,014 shares of common stock held by the Reporting Person."}],"balance_after":54861,"source":{"system":"sec-edgar","filing":"0001209191-19-022630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022630/doc4.xml","form_type":"4"}},{"id":3709620,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-03T21:07:05.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":1603,"price":3.18,"value":5097.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 13,852 restricted stock units which vest in three equal annual installments on January 1, 2020, 2021 and 2022; and (b) 3,014 shares of common stock held by the Reporting Person."}],"balance_after":16866,"source":{"system":"sec-edgar","filing":"0001209191-19-000884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119000884/doc4.xml","form_type":"4"}},{"id":3752249,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-11-27T21:45:55.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":44585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests in four equal annual installments on November 1, 2019, 2020, 2021 and 2022."}],"balance_after":44585,"derivative":{"exercise_price":3.79,"expiration_date":"2028-11-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":44585},"source":{"system":"sec-edgar","filing":"0001209191-18-060004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118060004/doc4.xml","form_type":"4"}},{"id":3752248,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-27T21:45:55.000Z","date":"2018-11-26","kind":"grant","acquired":true,"shares":18469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of restricted stock units which shall vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes a deferred stock award of 18,469 restricted stock units which vest in four equal annual installments on January 1, 2019, 2020, 2021 and 2022."}],"balance_after":18469,"source":{"system":"sec-edgar","filing":"0001209191-18-060004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118060004/doc4.xml","form_type":"4"}},{"id":4094367,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-19T19:48:43.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units shall be earned upon achievement of certain performance conditions and, if earned, shall vest on January 31, 2021."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-004656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919118004656/doc4.xml","form_type":"4"}},{"id":4161875,"issuer":{"id":147285,"kind":"organization","name":"TETRAPHASE PHARMACEUTICALS INC","symbol":"TTPH"},"owners":[{"id":158640,"kind":"person","name":"Unninayar Kamalam","position":1,"cik":"0001720065","reported_name":"Unninayar Kamalam","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-11-15T19:27:15.000Z","date":"2017-11-15","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four years. Twenty-five percent (25%) of the shares will vest on November 15, 2018 and 6.25% of the shares will vest at the end of each successive three month period thereafter."}],"balance_after":190000,"derivative":{"exercise_price":6.07,"expiration_date":"2027-11-14","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001209191-17-061004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1373707/000120919117061004/doc4.xml","form_type":"4"}}]}